Market closedNon-fractional

Repro Med Systems/KRMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Repro Med Systems

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Ticker

KRMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Mahwah, United States

Employees

-

KRMD Metrics

BasicAdvanced
$115M
Market cap
-
P/E ratio
-$0.29
EPS
0.53
Beta
-
Dividend rate
$115M
0.53
4.014
3.194
18.465
21.825
-17.44%
-54.24%
3.924
6
6.24
-92.599
0.96%
53.91%
8.00%
61.33%

What the Analysts think about KRMD

Analyst Ratings

Majority rating from 5 analysts.
Buy

KRMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-23.45% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.1M
14.08%
Net income
-$1.9M
-74.32%
Profit margin
-23.45%
-77.50%

KRMD Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 5.26%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.05
-$0.03
-$0.16
-$0.04
-
Expected
-$0.06
-$0.05
-$0.04
-$0.04
-$0.04
Surprise
-11.77%
-40.00%
300.00%
5.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Repro Med Systems stock?

Repro Med Systems (KRMD) has a market cap of $115M as of July 06, 2024.

What is the P/E ratio for Repro Med Systems stock?

The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of July 06, 2024.

Does Repro Med Systems stock pay dividends?

No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Repro Med Systems dividend payment date?

Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Repro Med Systems?

Repro Med Systems (KRMD) has a beta rating of 0.53. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Repro Med Systems stock

Buy or sell Repro Med Systems stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing